TCT 2016: Cardiologists Urge More Alignment Between EU And US Regs
Executive Summary
More robust oversight of medical devices in the EU is coming, and some European cardiologists speaking at the Transcatheter Cardiovascular Therapeutics annual meeting in Washington, DC, said that is a good thing despite the device industry’s history of praising the EU system for supporting innovation. They also pushed for more harmonization between the EU and US systems. Watch a video report from an FDA Town Hall panel at TCT on the topic and read our report from the meeting.
You may also be interested in...
Interview: EU Or US? Deciding On The Best Market Entry Point Amid Evolving Clinical Requirements
The timescale for CE-marking devices that require clinical studies may stretch to at least double the timescale for US 510(k) clearance as the EU landscape evolves, according to consultant Maria Donawa. In a Q&A with Medtech Insight, she assesses the ongoing changes and whether the clinical data requirement scales are tipping to such an extent that the US will increasingly be a favored point-of-market entry.
Will BMJ Study Linking EU-First Innovations With More Safety Alerts Prompt Tougher UK Regs?
Findings from a new study which link a much higher rate of safety alerts with innovative devices that are approved first in the EU before going through the US FDA has been picked up by UK Brexit supporters as evidence of Brussels’ failure to regulate devices.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.